Erasca (ERAS) Long-Term Investments (2021 - 2026)

Erasca (ERAS) reported Long-Term Investments of $164.7 million for Q1 2026, up 54.68% on a YoY basis from $106.5 million in Q1 2025, and up 150.63% quarter-over-quarter from $65.7 million in Q4 2025.

Erasca (ERAS) Long-Term Investments (2021 - 2026) Analysis & Trends

Erasca has reported Long-Term Investments for 6 years, with the latest figure at $164.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Long-Term Investments rose 54.68% year-over-year to $164.7 million; the trailing twelve-month figure through Mar 2026 stood at $164.7 million (up 54.68% YoY), and the FY2025 full-year result was $65.7 million, down 53.77% from the prior year.
  • Long-Term Investments for Q1 2026 stood at $164.7 million, up from $65.7 million in the prior quarter.
  • The five-year high for Long-Term Investments was $164.7 million in Q1 2026, with the low at $9.6 million in Q3 2022.
  • Historically, Long-Term Investments has averaged $71.3 million across 5 years, with a median of $58.8 million in 2024.
  • Annual changes were most pronounced in 2024 — Long-Term Investments soared 1374.42% — and 2025, when it slumped 53.77%.
  • Erasca's Long-Term Investments stood at $9.6 million in 2022, then grew by 0.44% to $9.6 million in 2023, then soared by 1374.42% to $142.2 million in 2024, then tumbled by 53.77% to $65.7 million in 2025, then soared by 150.63% to $164.7 million in 2026.
  • The last three Long-Term Investments figures came in at $164.7 million (Q1 2026), $65.7 million (Q4 2025), and $74.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.17 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Erasca 4.16 Bn 3.92 Bn - 164.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 164.72 Mn
Dec 31, 2025 65.72 Mn
Sep 30, 2025 73.98 Mn
Jun 30, 2025 86.09 Mn
Mar 31, 2025 106.49 Mn
Dec 31, 2024 142.16 Mn
Sep 30, 2024 144.40 Mn
Jun 30, 2024 51.80 Mn
Dec 31, 2023 9.64 Mn
Sep 30, 2023 46.90 Mn
Jun 30, 2023 48.08 Mn
Sep 30, 2022 9.60 Mn
Jun 30, 2022 19.30 Mn
Mar 31, 2022 29.22 Mn
Dec 31, 2021 44.77 Mn
Jun 30, 2021 5.00 Mn